U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H41N5O5S
Molecular Weight 499.667
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of REBIMASTAT

SMILES

CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](S)CCN1C(=O)N(C)C(C)(C)C1=O)C(C)(C)C

InChI

InChIKey=GTXSRFUZSLTDFX-HRCADAONSA-N
InChI=1S/C23H41N5O5S/c1-13(2)12-14(17(29)26-16(19(31)24-8)22(3,4)5)25-18(30)15(34)10-11-28-20(32)23(6,7)27(9)21(28)33/h13-16,34H,10-12H2,1-9H3,(H,24,31)(H,25,30)(H,26,29)/t14-,15-,16+/m0/s1

HIDE SMILES / InChI
Molecular Formula C23H41N5O5S
Molecular Weight 499.667
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:38:55 UTC 2023
Edited
by admin
on Fri Dec 15 15:38:55 UTC 2023
Record UNII
1B47R6ZX4K
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
REBIMASTAT
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
Rebimastat [WHO-DD]
Common Name English
BMS-275291
Code English
(2S)-N-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-4-methyl-2-[[(2S)-2-sulfanyl-4-(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)butanoyl]amino]pentanamide
Systematic Name English
D2163
Code English
BMS 275291-01
Code English
rebimastat [INN]
Common Name English
BMS-275291-01
Code English
REBIMASTAT [USAN]
Common Name English
L-VALINAMIDE, N-((2S)-2-MERCAPTO-1-OXO-4-(3,4,4-TRIMETHYL-2,5-DIOXO-1-IMIDAZOLIDINYL)BUTYL)-L-LEUCYL-N,3-DIMETHYL-
Systematic Name English
D-2163
Code English
Classification Tree Code System Code
NCI_THESAURUS C1970
Created by admin on Fri Dec 15 15:38:55 UTC 2023 , Edited by admin on Fri Dec 15 15:38:55 UTC 2023
Code System Code Type Description
PUBCHEM
9913881
Created by admin on Fri Dec 15 15:38:55 UTC 2023 , Edited by admin on Fri Dec 15 15:38:55 UTC 2023
PRIMARY
FDA UNII
1B47R6ZX4K
Created by admin on Fri Dec 15 15:38:55 UTC 2023 , Edited by admin on Fri Dec 15 15:38:55 UTC 2023
PRIMARY
EPA CompTox
DTXSID80948835
Created by admin on Fri Dec 15 15:38:55 UTC 2023 , Edited by admin on Fri Dec 15 15:38:55 UTC 2023
PRIMARY
SMS_ID
100000126188
Created by admin on Fri Dec 15 15:38:55 UTC 2023 , Edited by admin on Fri Dec 15 15:38:55 UTC 2023
PRIMARY
CAS
259188-38-0
Created by admin on Fri Dec 15 15:38:55 UTC 2023 , Edited by admin on Fri Dec 15 15:38:55 UTC 2023
PRIMARY
USAN
MM-64
Created by admin on Fri Dec 15 15:38:55 UTC 2023 , Edited by admin on Fri Dec 15 15:38:55 UTC 2023
PRIMARY
EVMPD
SUB32855
Created by admin on Fri Dec 15 15:38:55 UTC 2023 , Edited by admin on Fri Dec 15 15:38:55 UTC 2023
PRIMARY
INN
8167
Created by admin on Fri Dec 15 15:38:55 UTC 2023 , Edited by admin on Fri Dec 15 15:38:55 UTC 2023
PRIMARY
ChEMBL
CHEMBL76222
Created by admin on Fri Dec 15 15:38:55 UTC 2023 , Edited by admin on Fri Dec 15 15:38:55 UTC 2023
PRIMARY
NCI_THESAURUS
C1875
Created by admin on Fri Dec 15 15:38:55 UTC 2023 , Edited by admin on Fri Dec 15 15:38:55 UTC 2023
PRIMARY
DRUG BANK
DB06573
Created by admin on Fri Dec 15 15:38:55 UTC 2023 , Edited by admin on Fri Dec 15 15:38:55 UTC 2023
PRIMARY
Related Record Type Details
MATRIX METALLOPROTEINASE-9
TARGET -> INHIBITOR
INTERSTITIAL COLLAGENASE
TARGET -> INHIBITOR
MATRIX METALLOPROTEINASE-14
TARGET -> INHIBITOR
72 KDA TYPE IV COLLAGENASE
TARGET -> INHIBITOR
NEUTROPHIL COLLAGENASE
TARGET -> INHIBITOR
Related Record Type Details
Structure of REBIMASTAT
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966